IB-08C175

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameIB-08C175
Drug Alias NameIB-08C175
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsGraft vs Host DiseaseMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiomar Microbial Technologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsGraft vs Host DiseaseMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A